Search Results - "Lubaki, Ndongala Michel"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm by Younan, Patrick, Iampietro, Mathieu, Nishida, Andrew, Ramanathan, Palaniappan, Santos, Rodrigo I, Dutta, Mukta, Lubaki, Ndongala Michel, Koup, Richard A, Katze, Michael G, Bukreyev, Alexander

    Published in mBio (26-09-2017)
    “…Ebola virus (EBOV) disease (EVD) results from an exacerbated immunological response that is highlighted by a burst in the production of inflammatory mediators…”
    Get full text
    Journal Article
  3. 3

    Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection by Iampietro, Mathieu, Younan, Patrick, Nishida, Andrew, Dutta, Mukta, Lubaki, Ndongala Michel, Santos, Rodrigo I, Koup, Richard A, Katze, Michael G, Bukreyev, Alexander

    Published in PLoS pathogens (01-05-2017)
    “…Fatal outcomes of Ebola virus (EBOV) infections are typically preceded by a 'sepsis-like' syndrome and lymphopenia despite T cells being resistant to Ebola…”
    Get full text
    Journal Article
  4. 4

    Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation by Iampietro, Mathieu, Santos, Rodrigo I, Lubaki, Ndongala Michel, Bukreyev, Alexander

    Published in The Journal of infectious diseases (22-11-2018)
    “…A better understanding of the mechanisms used by Ebola virus to disable the host immune system and spread the infection are of great importance for development…”
    Get full text
    Journal Article
  5. 5

    The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses by Lubaki, Ndongala Michel, Younan, Patrick, Santos, Rodrigo I, Meyer, Michelle, Iampietro, Mathieu, Koup, Richard A, Bukreyev, Alexander

    Published in PLoS pathogens (08-12-2016)
    “…Ebola virus (EBOV) infections are characterized by deficient T-lymphocyte responses, T-lymphocyte apoptosis and lymphopenia. We previously showed that…”
    Get full text
    Journal Article
  6. 6

    Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV by Liu, Dongfang, Tian, Shuo, Zhang, Kai, Xiong, Wei, Lubaki, Ndongala Michel, Chen, Zhiying, Han, Weidong

    Published in Protein & cell (01-12-2017)
    “…Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells contribute to the body's immune defenses. Current chimeric antigen receptor (CAR)-modified T cell…”
    Get full text
    Journal Article
  7. 7

    Community preparedness for HIV vaccine trials in the Democratic Republic of Congo by Olin, John, Kokolamami, Jacques, Lepira, Francois B., Mwandagalirwa, Kashamuka, Mupenda, Bavon, Ndongala, Michel Lubaki, Maman, Suzanne, Bollinger, Robert, Nachega, Jean, Mokili, John

    Published in Culture, health & sexuality (01-11-2006)
    “…This paper reports on an assessment of community preparedness for HIV vaccine trials in the Democratic Republic of Congo. Formative research was conducted in…”
    Get full text
    Journal Article
  8. 8

    Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV by Dongfang Liu;Shuo Tian;Kai Zhang;Wei Xiong;Ndongala Michel Lubaki;Zhiying Chen;Weidong Han

    Published in 蛋白质与细胞:英文版 (2017)
    “…Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells contribute to the body's immune defenses. Current chimeric antigen receptor (CAR)-modified T cell…”
    Get full text
    Journal Article
  9. 9

    HIV-specific immunity in Acute Infection Early disease (AIED) by Lubaki, Ndongala Michel

    Published 01-01-2009
    “…An estimated 33 millions of individuals are currently infected with HIV worldwide; the majority of them lives in Sub-Saharan Africa and do not have access to…”
    Get full text
    Dissertation